This cascade of the events described above includes the potential involvement of TMAO in the biomarker-expression associated with inflammation (IL-6, TNFα, and CRP) and endothelial dysfunction (ET-1) in the setting of increased gut permeability related to zonulin and linked to increased serum levels of LPS endotoxin. The gene discussed is EDN1; the disease is endothelial dysfunction.